Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

3rd Quarter Results

25 Nov 2020 16:00

RNS Number : 5251G
British Smaller Companies VCT2 Plc
25 November 2020
 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 30 September 2020

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 30 September 2020. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company's Total Return at 30 September 2020 was 120.6 pence per ordinary share, representing an increase of 3.7 pence per ordinary share over the Total Return of 116.9 pence per ordinary share as at 30 June 2020.

Performance

The movement in Total Return in pence per ordinary share is set out in the table below:

Pence per

ordinary share

Cumulative dividends to 30 June 2020

68.5

Net Asset Value ("NAV") at 30 June 2020

48.4

Total Return at 30 June 2020

116.9

Increase in portfolio value

Value realised as income

Net movement in portfolio value

3.9

(1.5)

2.4

Net income after expenses / share buy-backs

1.3

Increase in Total Return

3.7

Total Return at 30 September 2020

120.6

The value of the portfolio increased by 3.9 pence per share, equivalent to 8.1 per cent of the Net Asset Value at 30 June 2020. Of this increase £1.9 million from ACC Aviation was crystalised as a dividend payment to the Company which is shown in the net income after expenses.

30 June 2020

Increase in Value

Issue under DRIS / buyback of shares

Dividends

Movement

In Period

30 September 2020

Net Assets (£m)

62.6

4.8

0.2

(1.9)

3.1

65.7

NAV per share (PPS)

48.4p

3.7p

-

(1.5p)

2.2p

50.6p

Cumulative dividends paid (PPS)

68.5p

-

-

1.5p

1.5p

70.0p

Total Return (PPS)

116.9p

3.7p

-

-

3.7p

120.6p

Shares in issue

129,373,784

-

481,632

-

481,632

129,855,416

 

The Total Return at 30 September 2020, calculated by reference to the NAV per ordinary share and the cumulative dividends paid per ordinary share, was 120.6 pence per ordinary share compared to 116.9 pence per ordinary share at 30 June 2020.

The unaudited NAV per ordinary share increased from 48.4 pence per share to 52.1 pence per share, equivalent to 7.6 per cent in the period. Of this increase 1.5 pence per ordinary share was paid as an interim dividend on 21 September 2020, taking cumulative dividends paid at 30 September 2020 to 70.0 pence per ordinary share (30 June 2020: 68.5 pence per ordinary share). The resultant Net Asset Value at the end of the period is 50.6 pence per share.

The movements in NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 30 June 2020

62.6

48.4

Increase in portfolio value

5.0

3.9

Value realised as income

(1.9)

(1.5)

Net movement in portfolio

3.1

2.4

Net income after expenses

1.7

1.3

Issue/buy-back of shares

0.2

-

5.0

3.7

NAV before payment of dividend

67.6

52.1

Dividend paid

(1.9)

(1.5)

NAV at 30 September 2020

65.7

50.6

Dividends and shares in issue

On 25 September 2020 the Company purchased 441,258 ordinary shares of 10 pence each at a price of 45.00 pence per ordinary share. These shares were placed in treasury.

Following the payment of the interim dividend of 1.5 pence per share on 21 September 2020 the Company issued 922,890 ordinary shares under the DRIS.

The number of ordinary shares in issue at 30 September 2020 was 129,855,416 (30 June 2020: 129,373,784). In addition, at 30 September 2020 the Company held 11,477,112 ordinary shares in treasury (30 June 2020: 11,035,854).

Dividend Re-Investment Scheme

Following a review of market practice the Board has decided that future issues of shares under the Company's DRIS will be re-invested at the last reported net asset value, as adjusted for the relevant dividend in question if this has not already been recognised. The Company will be writing to shareholders to give them the required one month's notice of this change.

Net assets

Net assets at 30 September 2020 comprised the following:

£000

% of net assets

Unquoted investments

39,911

60.7%

Cash and cash equivalents

25,277

38.5%

Other net current assets

547

0.8%

Net assets

65,735

100%

 

The investment portfolio at 30 September 2020 comprised:

Valuation

£000

Valuation as a % of net assets

Matillion Limited

8,895

13.5%

Intelligent Office UK Limited

3,185

4.8%

ACC Aviation Group Limited

3,060

4.7%

Unbiased EC1 Limited

2,449

3.7%

Springboard Research Holdings Limited

2,424

3.7%

KeTech Enterprises Limited

2,283

3.5%

Arcus Global Limited

2,136

3.2%

Deep-Secure Limited

1,698

2.6%

Elucidat Limited

1,580

2.4%

Wooshii Limited

1,519

2.3%

29,229

44.4%

Other investments

10,682

16.3%

Total investments

39,911

60.7%

 

Investments made prior to the November 2015 Budget represented 41 per cent of the value of the unquoted portfolio at 30 September 2020.

On 20 November 2020 the Company invested £1.6 million into Leeds based marketing automation software business Force24.

Portfolio performance

Over the quarter to 30 September 2020 the aggregate unrealised portfolio valuation has increased by £5.0 million prior to recognising the £1.9 million ordinary dividend received from ACC Aviation.

Board composition

As previously announced Barbara Anderson joined the Board as an independent non-executive director with effect from 1 October 2020, and Robert Pettigrew will resign as a director on 31 December 2020.

Shareholder relations

Your Company will be holding an on-line version of the investor workshop on 14 December 2020, details of which have been communicated to shareholders.

Outlook

The portfolio has adapted well to the various restrictions imposed as a result of the coronavirus pandemic and valuations have continued to recover. Demand for growth capital continues, as the recent investment in Force24 shows and the Company continues to look for opportunities in innovative businesses and growing sectors. The Company is well positioned to provide further funding for these opportunities and to the portfolio as its investments seek to further expand and, where appropriate, accelerate their growth plans.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

25 November 2020

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTPPGMWGUPUGAA
Date   Source Headline
6th May 20267:00 amRNSDividend Declaration
20th Apr 202610:01 amRNSAdmission to Trading
1st Apr 20269:00 amRNSIssue of Equity
27th Mar 20264:12 pmRNSTransaction in Own Shares
23rd Mar 202610:45 amRNSPublication of a Supplementary Prospectus
19th Mar 20267:00 amRNSAnnual Financial Report
30th Jan 20267:00 amRNSAdmission of Further Securities to Trading
7th Jan 20269:31 amRNSDirector/PDMR Shareholding
7th Jan 20269:30 amRNSIssue of Equity
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
22nd Dec 20259:13 amRNSTransaction in Own Shares
22nd Dec 20259:13 amRNSTransaction in Own Shares
18th Dec 202512:14 pmRNSClose of Offers to new Applications
18th Dec 202512:14 pmRNSClose of Offers to new Applications
28th Nov 202510:00 amRNSInterim Management Statement
20th Nov 20259:00 amRNSOffer Update
31st Oct 202510:01 amRNSPayment of dividend and issue of Equity
10th Oct 20253:41 pmRNSOffer Update
2nd Oct 20259:00 amRNSOffer Update
25th Sep 20259:04 amRNSPublication of a Prospectus
23rd Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSHalf-year Report
22nd Aug 202510:45 amRNSNew combined offer for subscription
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 202510:20 amRNSPayment of Dividend and Issue of Equity
13th Jun 20251:30 pmRNSInterim Management Statement
12th Jun 202510:46 amRNSResult of AGM
13th May 202512:54 pmRNSDividend Declaration
1st Apr 20258:02 amRNSDirector/PDMR Shareholding
1st Apr 20258:00 amRNSIssue of Equity
26th Mar 20255:15 pmRNSTransaction in Own Shares
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
18th Mar 20251:00 pmRNSAnnual Financial Report
30th Jan 20259:05 amRNSDirector/PDMR Shareholding
30th Jan 20259:00 amRNSIssue of Equity
27th Jan 20259:21 amRNSPayment of dividend and issue of shares
8th Jan 20252:14 pmRNSClose of Offer to new Applications
8th Jan 20252:13 pmRNSClose of Offer to new Applications
17th Dec 20242:13 pmRNSNominal Capital Reduction
17th Dec 20247:00 amRNSDividend Declaration
16th Dec 20245:08 pmRNSTransaction in Own Shares
29th Nov 20249:00 amRNS3rd Quarter Results
20th Nov 20241:00 pmRNSOffer Update
20th Nov 20241:00 pmRNSOffer Update
12th Nov 20241:52 pmRNSResult of General Meeting
1st Nov 202411:04 amRNSPayment of Dividend and Allotment of Shares
1st Nov 20247:00 amRNSOffer Update
1st Nov 20247:00 amRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.